8 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 8 of 8 clinical reviews.
A prescriber-level guide to progestin pharmacology, formulary positioning, and prior-authorization strategy for micronized progesterone and synthetic progestins in menopausal HRT and luteal support.
Evidence-based monitoring protocol for micronized progesterone and synthetic progestins in menopausal HRT and luteal support, including lab panels, imaging schedules, and safety checkpoints.
A prescriber-level guide to managing adverse events from micronized progesterone and synthetic progestins, covering class differences, dose adjustments, and evidence-based switching protocols for HRT and luteal support.
A prescriber-level monograph comparing micronized progesterone with synthetic progestins across HRT, luteal support, and cardiovascular risk. Includes dosing, pharmacology, clinical trial data, and guideline recommendations.
A complete drug-drug interaction table comparing micronized progesterone vs synthetic progestins, with dosing, metabolism pathways, and clinical prescribing guidance for HRT and luteal support.
A prescriber-level review of micronized progesterone versus synthetic progestins across special populations: pregnancy, menopause, cardiovascular risk, breast cancer history, liver disease, and more. Includes dosing, trial data, and guideline recommendations.
A prescriber-level guide to oral micronized progesterone and synthetic progestins: pharmacology, dosing titration, tapering protocols, and clinical decision frameworks for menopausal HRT and luteal support.
Evidence-based guide for clinicians on selecting between micronized progesterone and synthetic progestins for menopausal HRT, luteal support, and endometrial protection. Covers pharmacology, trial data, breast risk, and patient-specific decision points.